# Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients

> **NCT04465981** · — · UNKNOWN · sponsor: **INanoBio Inc.** · enrollment: 80 (estimated)

## Conditions studied

- COVID-19
- SARS-CoV-2 Infection

## Interventions

- **DIAGNOSTIC_TEST:** Sampling

## Key facts

- **NCT ID:** NCT04465981
- **Lead sponsor:** INanoBio Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-03
- **Primary completion:** 2022-06
- **Final completion:** 2022-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04465981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04465981, "Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04465981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*